Conference Description:

Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development and Screening Summit returns as the first and only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, unravel the MOA, progress beyond CRBN and VHL, improve high throughput methods and progress from early discovery to drug candidate with scalable compounds.

With promise shown using technologies like DELs, CryoEM and HDX-MS, join us as we take a deep dive into the persisting challenges holding back the progression of candidates into pre-clinical studies by exploring the best methodologies at your disposal across AI/ML guided structure-based drug design, proteomics-led, or cell-based assay approaches.


URL:
Tickets: https://go.evvnt.com/1854106-2?pid=154
Time: 8:00 AM - 5:00 PM

Prices:
Conference + Workshop Day - Drug Developer Pricing: USD 5146.00,
Conference + Workshop Day - Academic Pricing: USD 4446.00,
Conference + Workshop Day - Vendor Pricing: USD 6146.00,
Conference Only - Drug Developer Pricing: USD 3199.00,
Conference Only - Academic Pricing: USD 2799.00,
Conference Only - Vendor Pricing: USD 3899.00,
Workshop Day Only - Drug Developer Pricing: USD 2347.00,
Workshop Day Only - Academic Pricing: USD 2047.00,
Workshop Day Only - Vendor Pricing: USD 2647.00

Speakers: Anand Ramanathan, Associate Director, Lead Discovery, Kymera Therapeutics, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Bradlee Heckmann, Chief Scientific Officer, Asha Therapeutics, Bradley DeMarco, Senior Scientist, Monte Rosa Therapeutics, Charu Chaudhry, Senior Principal Scientist, Janssen, James Iuliano, Scientist II, Nurix Therapeutics, Jian Tang, Scientist, BMS, Jin Wang, Professor, Baylor College of Medicine, Justin Reitsma, Principal Research Scientist, Abbvie, Levon Halabelian, Associate Professor and Principal Investigator, University of Toronto, Lu Zhu, Scientist, Janssen, Margaret Biddle, Director, Medicinal Chemistry, Entact Bio, Marvin Yu, Vice President of Platform Chemistry, Enveda Biosciences, Michelle Arkin, Professor and Chair, Pharmaceutical Chemistry, University of California San Francisco, Oscar Huang, Associate Director of Biophysics, Lyterian, Peggy Thompson, Vice President of Biology, Plexium, Prakash Palde, Associate Fellow of Research and Lead Discovery, Pfizer, Richard Somberg, Richard Somberg Director, Pharma/ Biotech Market Segment, Promega, Ryan Emerson, Vice President of Data Science, A-Alpha Bio, Ryan McClure, Senior Scientist, Abbvie, Shuo Wang, Principal Scientist, Pfizer, Ted Suh, Vice President, Chemistry, Orionis Biosciences, Yang Xie, Senior Vice President, NeoX Biotech